C D Buckner|R A Clift - JoVE Visualize

Showing results (221-230 of 306) with videos related to

Pageof 31

Sort By:

Pharmacoeconomics|June 7, 1994

Recombinant human granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer: an economic analysis of a randomised, double-blind, placebo-controlled trialB R Luce, J W Singer, J M Weschler, et al.

Blood|May 1, 1991

Phase I/II trial of recombinant human granulocyte-macrophage colony-stimulating factor following allogeneic bone marrow transplantationJ Nemunaitis, C D Buckner, F R Appelbaum, et al.

Experimental Hematology|March 1, 1987

Treatment of aplastic anemia with antithymocyte globulin, high-dose corticosteroids, and androgensK Doney, R Storb, C D Buckner, et al.

Bone Marrow Transplantation|October 1, 1994

Phase I study of recombinant human interleukin-1 beta (rhIL-1 beta) in patients with bone marrow failureJ Nemunaitis, M Ross, B Meisenberg, et al.

Bone Marrow Transplantation|July 1, 1996

High-dose fractionated total-body irradiation, etoposide and cyclophosphamide for treatment of malignant lymphoma: comparison of autologous bone marrow and peripheral blood stem cellsM W Brunvand, W I Bensinger, E Soll, et al.

Blood|October 1, 1993

Syngeneic transplantation with peripheral blood mononuclear cells collected after the administration of recombinant human granulocyte colony-stimulating factorC H Weaver, C D Buckner, K Longin, et al.

Bone Marrow Transplantation|April 1, 1996

Busulfan, cyclophosphamide and fractionated total body irradiation for autologous or syngeneic marrow transplantation for acute and chronic myelogenous leukemia: phase I dose escalation of busulfan based on targeted plasma levelsT Demirer, C D Buckner, F R Appelbaum, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1987

Marrow transplantation for acute nonlymphocytic leukemia following therapy for Hodgkin's diseaseM Sargur, C D Buckner, F R Appelbaum, et al.

Bone Marrow Transplantation|June 1, 1995

Influence of total nucleated cell dose from marrow harvests on outcome in patients with acute myelogenous leukemia undergoing autologous transplantationT Demirer, T Gooley, C D Buckner, et al.

Bone Marrow Transplantation|June 1, 1995

Rapid engraftment after autologous transplantation utilizing marrow and recombinant granulocyte colony-stimulating factor-mobilized peripheral blood stem cells in patients with acute myelogenous leukemiaT Demirer, C D Buckner, F R Appelbaum, et al.

Pageof 31

Showing results (221-230 of 306) with videos related to

Sort By:

Pageof 31

Pharmacoeconomics|June 7, 1994

Recombinant human granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer: an economic analysis of a randomised, double-blind, placebo-controlled trialB R Luce, J W Singer, J M Weschler, et al.

Blood|May 1, 1991

Phase I/II trial of recombinant human granulocyte-macrophage colony-stimulating factor following allogeneic bone marrow transplantationJ Nemunaitis, C D Buckner, F R Appelbaum, et al.

Experimental Hematology|March 1, 1987

Treatment of aplastic anemia with antithymocyte globulin, high-dose corticosteroids, and androgensK Doney, R Storb, C D Buckner, et al.

Bone Marrow Transplantation|October 1, 1994

Phase I study of recombinant human interleukin-1 beta (rhIL-1 beta) in patients with bone marrow failureJ Nemunaitis, M Ross, B Meisenberg, et al.

Bone Marrow Transplantation|July 1, 1996

High-dose fractionated total-body irradiation, etoposide and cyclophosphamide for treatment of malignant lymphoma: comparison of autologous bone marrow and peripheral blood stem cellsM W Brunvand, W I Bensinger, E Soll, et al.

Blood|October 1, 1993

Syngeneic transplantation with peripheral blood mononuclear cells collected after the administration of recombinant human granulocyte colony-stimulating factorC H Weaver, C D Buckner, K Longin, et al.

Bone Marrow Transplantation|April 1, 1996

Busulfan, cyclophosphamide and fractionated total body irradiation for autologous or syngeneic marrow transplantation for acute and chronic myelogenous leukemia: phase I dose escalation of busulfan based on targeted plasma levelsT Demirer, C D Buckner, F R Appelbaum, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1987

Marrow transplantation for acute nonlymphocytic leukemia following therapy for Hodgkin's diseaseM Sargur, C D Buckner, F R Appelbaum, et al.

Bone Marrow Transplantation|June 1, 1995

Influence of total nucleated cell dose from marrow harvests on outcome in patients with acute myelogenous leukemia undergoing autologous transplantationT Demirer, T Gooley, C D Buckner, et al.

Bone Marrow Transplantation|June 1, 1995

Rapid engraftment after autologous transplantation utilizing marrow and recombinant granulocyte colony-stimulating factor-mobilized peripheral blood stem cells in patients with acute myelogenous leukemiaT Demirer, C D Buckner, F R Appelbaum, et al.

Pageof 31